Greg Yothers

17PUBLICATIONS
97CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual disease.

|Apr 04, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization Tool.

Gillian Gresham, Michael Luu, N Lynn Henry

|Sep 04, 2024
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.

Benoist Chibaudel, Morteza Raeisi, Romain Cohen

|Jul 16, 2024
Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability Data.

Michael Luu, Gillian Gresham, Lynn Henry

|Mar 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.

Claire Gallois, Qian Shi, Levi D Pederson

|Feb 09, 2024
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).

Charles E Geyer, Joanne L Blum, Greg Yothers

Pageof 3

Frequent Collaborators

7 joint publications

Thomas J George

6 joint publications

Richard R M Goldberg

5 joint publications

Qian Shi

5 joint publications

Patricia A Ganz